Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals.
暂无分享,去创建一个
J. Kleinman | R. Schwarcz | P. Langenberg | T. Hyde | T. Postolache, | S. Clark | L. Tonelli | J. D. Nicholson | J. Stiller | F. Notarangelo | R. Mcmahon | A. Pocivavsek | Ana Pocivavsek
[1] O. Andreassen,et al. Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers , 2015, Psychoneuroendocrinology.
[2] B. Bogerts,et al. Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses? , 2015, European Archives of Psychiatry and Clinical Neuroscience.
[3] Teresa A. Victor,et al. Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder , 2015, Brain, Behavior, and Immunity.
[4] Alan A. Wilson,et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. , 2015, JAMA psychiatry.
[5] C. Lim,et al. A role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality , 2015, Brain, Behavior, and Immunity.
[6] G. Turecki,et al. Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides , 2014, Brain, Behavior, and Immunity.
[7] T. Dinan,et al. Acute tryptophan depletion reduces kynurenine levels: implications for treatment of impaired visuospatial memory performance in irritable bowel syndrome , 2014, Psychopharmacology.
[8] G. Rosoklija,et al. Microglia of Prefrontal White Matter in Suicide , 2014, Journal of neuropathology and experimental neurology.
[9] B. Penninx,et al. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms? , 2014, Psychoneuroendocrinology.
[10] S. Maier,et al. Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis , 2014, Molecular Psychiatry.
[11] Andrew H. Miller,et al. Malaise, melancholia and madness: The evolutionary legacy of an inflammatory bias , 2013, Brain, Behavior, and Immunity.
[12] C. Zarate,et al. New paradigms for treatment‐resistant depression , 2013, Annals of the New York Academy of Sciences.
[13] B. Dean,et al. Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders , 2013, Molecular Psychiatry.
[14] Andrew H. Miller,et al. CYTOKINE TARGETS IN THE BRAIN: IMPACT ON NEUROTRANSMITTERS AND NEUROCIRCUITS , 2013, Depression and anxiety.
[15] S. Janelidze,et al. Connecting inflammation with glutamate agonism in suicidality , 2012, Neuropsychopharmacology.
[16] P. Pregelj,et al. Neurobiology of suicidal behaviour. , 2012, Psychiatria Danubina.
[17] T. Lehtimäki,et al. Indoleamine 2,3-Dioxygenase Activation and Depressive Symptoms: Results From the Young Finns Study , 2012, Psychosomatic medicine.
[18] T. Postolache,et al. Neuroinflammation and depression: the role of indoleamine 2,3-dioxygenase (IDO) as a molecular pathway. , 2012, Psychosomatic Medicine.
[19] Shuxing Wang,et al. Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. , 2012, The Journal of clinical investigation.
[20] F. Amico,et al. Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation , 2012, Brain, Behavior, and Immunity.
[21] R. Schwarcz,et al. Kynurenines in the mammalian brain: when physiology meets pathology , 2012, Nature Reviews Neuroscience.
[22] A. Manatunga,et al. Neurobehavioral Effects of Interferon-α in Patients with Hepatitis-C: Symptom Dimensions and Responsiveness to Paroxetine , 2012, Neuropsychopharmacology.
[23] Victoria Arango,et al. Neuron density and serotonin receptor binding in prefrontal cortex in suicide. , 2012, The international journal of neuropsychopharmacology.
[24] R. Schwarcz,et al. Gas chromatography/tandem mass spectrometry detection of extracellular kynurenine and related metabolites in normal and lesioned rat brain. , 2012, Analytical biochemistry.
[25] Benjamin A. Ely,et al. The possible role of the kynurenine pathway in anhedonia in adolescents , 2012, Journal of Neural Transmission.
[26] J. Price,et al. Neural circuits underlying the pathophysiology of mood disorders , 2012, Trends in Cognitive Sciences.
[27] F. Moroni,et al. Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery , 2012, Journal of Neural Transmission.
[28] B. Bogerts,et al. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission? , 2011, Journal of Neuroinflammation.
[29] J. Mann,et al. Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder , 2011, Brain, Behavior, and Immunity.
[30] R. Schwarcz,et al. Fluctuations in Endogenous Kynurenic Acid Control Hippocampal Glutamate and Memory , 2011, Neuropsychopharmacology.
[31] P. Kelly,et al. Mechanism of acute tryptophan depletion: is it only serotonin? , 2011, Molecular Psychiatry.
[32] Andrew H. Miller,et al. Immune system to brain signaling: neuropsychopharmacological implications. , 2011, Pharmacology & therapeutics.
[33] J. Babb,et al. The possible role of the kynurenine pathway in adolescent depression with melancholic features. , 2010, Journal of child psychology and psychiatry, and allied disciplines.
[34] M Aschner,et al. ALTERED EXPRESSION OF GENES INVOLVED IN INFLAMMATION AND APOPTOSIS IN FRONTAL CORTEX IN MAJOR DEPRESSION , 2010, Molecular Psychiatry.
[35] J. Babb,et al. The kynurenine pathway in adolescent depression: Preliminary findings from a proton MR spectroscopy study , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[36] R. Dantzer,et al. CSF Concentrations of Brain Tryptophan and Kynurenines during Immune Stimulation with IFN-alpha: Relationship to CNS Immune Responses and Depression , 2009, Molecular Psychiatry.
[37] Jordan Grafman,et al. The functional neuroanatomy of depression: Distinct roles for ventromedial and dorsolateral prefrontal cortex , 2009, Behavioural Brain Research.
[38] Hae-Chul Park,et al. Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants , 2008, Neuropharmacology.
[39] Thomas D. Schmittgen,et al. Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.
[40] S. Weis,et al. Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder , 2008, Neurochemistry International.
[41] D F Swaab,et al. Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances , 2008, Molecular Psychiatry.
[42] D. Rujescu,et al. Elevated cytokine expression in the orbitofrontal cortex of victims of suicide , 2008, Acta psychiatrica Scandinavica.
[43] W. Drevets,et al. Orbitofrontal Cortex Function and Structure in Depression , 2007, Annals of the New York Academy of Sciences.
[44] M. Maes,et al. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation. , 2007, Neuro endocrinology letters.
[45] M. Schwarz,et al. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression , 2007, Molecular Psychiatry.
[46] E. Altschuler,et al. A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. , 2006, International immunopharmacology.
[47] S. Weis,et al. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder , 2006, Brain Research.
[48] Peter Herscovitch,et al. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. , 2004, Archives of general psychiatry.
[49] P. Cuijpers,et al. Minor depression: risk profiles, functional disability, health care use and risk of developing major depression. , 2004, Journal of affective disorders.
[50] C. Nemeroff,et al. Interferon-alpha–induced changes in tryptophan metabolism relationship to depression and paroxetine treatment , 2003, Biological Psychiatry.
[51] T. Pollmächer,et al. Low levels of circulating inflammatory cytokines—Do they affect human brain functions? , 2002, Brain, Behavior, and Immunity.
[52] R. Dantzer,et al. Cytokines and depression: An update , 2002, Brain, Behavior, and Immunity.
[53] E. Bosmans,et al. Anti-Inflammatory Effects of Antidepressants Through Suppression of the Interferon-γ/Interleukin-10 Production Ratio , 2001, Journal of clinical psychopharmacology.
[54] V. Arango,et al. Postmortem Findings in Suicide Victims. Implications for in Vivo Imaging Studies a , 1997, Annals of the New York Academy of Sciences.
[55] Andrew H. Miller,et al. Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior , 2012, Neuropsychopharmacology.
[56] Yogesh K. Dwivedi,et al. Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. , 2012, Journal of psychiatric research.
[57] B. Dean,et al. Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder. , 2010, Journal of affective disorders.
[58] R. Schwarcz,et al. The Astrocyte-Derived α7 Nicotinic Receptor Antagonist Kynurenic Acid Controls Extracellular Glutamate Levels in the Prefrontal Cortex , 2009, Journal of Molecular Neuroscience.
[59] R. Schwarcz,et al. Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry , 2007, Glia.
[60] M. Maes,et al. IDO and interferon-α-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity , 2005, Molecular Psychiatry.
[61] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .